JP2000515370A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000515370A5 JP2000515370A5 JP1998505608A JP50560898A JP2000515370A5 JP 2000515370 A5 JP2000515370 A5 JP 2000515370A5 JP 1998505608 A JP1998505608 A JP 1998505608A JP 50560898 A JP50560898 A JP 50560898A JP 2000515370 A5 JP2000515370 A5 JP 2000515370A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9614871.3A GB9614871D0 (en) | 1996-07-15 | 1996-07-15 | Compounds |
| GB9614871.3 | 1996-07-15 | ||
| PCT/EP1997/003715 WO1998002454A2 (en) | 1996-07-15 | 1997-07-08 | Conjugates of soluble peptidic compounds with membrane-binding agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000515370A JP2000515370A (ja) | 2000-11-21 |
| JP2000515370A5 true JP2000515370A5 (enExample) | 2005-07-14 |
| JP4177457B2 JP4177457B2 (ja) | 2008-11-05 |
Family
ID=10796956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50560898A Expired - Fee Related JP4177457B2 (ja) | 1996-07-15 | 1997-07-08 | 膜結合剤と可溶性ペプヂド性化合物の結合体 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US6713606B1 (enExample) |
| EP (1) | EP0912730B1 (enExample) |
| JP (1) | JP4177457B2 (enExample) |
| AR (1) | AR007737A1 (enExample) |
| AT (1) | ATE419345T1 (enExample) |
| AU (1) | AU732725B2 (enExample) |
| CA (1) | CA2260288A1 (enExample) |
| CO (1) | CO4750673A1 (enExample) |
| DE (1) | DE69739186D1 (enExample) |
| DK (1) | DK0912730T3 (enExample) |
| ES (1) | ES2321245T3 (enExample) |
| GB (1) | GB9614871D0 (enExample) |
| IL (3) | IL128034A0 (enExample) |
| NZ (1) | NZ333722A (enExample) |
| TW (1) | TW538048B (enExample) |
| WO (1) | WO1998002454A2 (enExample) |
| ZA (1) | ZA976216B (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9614871D0 (en) * | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
| US6210707B1 (en) | 1996-11-12 | 2001-04-03 | The Regents Of The University Of California | Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| GB9704519D0 (en) * | 1997-03-05 | 1997-04-23 | Smithkline Beecham Plc | Compounds |
| WO1999028454A1 (en) | 1997-11-28 | 1999-06-10 | Roche Diagnostics Gmbh | An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| ES2252886T3 (es) | 1998-04-30 | 2006-05-16 | Curis, Inc. | Conjugado de proteinas de erizo activo, proceso para su produccion y uso. |
| GB9815505D0 (en) * | 1998-07-16 | 1998-09-16 | Adprotech Plc | Polypeptide derivatives |
| GB9905503D0 (en) * | 1999-03-10 | 1999-05-05 | Adprotech Plc | Novel compound formulations and methods of delivery |
| GB0016811D0 (en) * | 2000-07-07 | 2000-08-30 | Adprotech Ltd | Lipid rafts |
| GB0026924D0 (en) | 2000-11-03 | 2000-12-20 | Univ Cambridge Tech | Antibacterial agents |
| GB0117193D0 (en) * | 2001-07-13 | 2001-09-05 | Adprotech Ltd | Protein modification reagents |
| GB0123262D0 (en) * | 2001-09-27 | 2001-11-21 | Adprotech Ltd | Polymeric compounds |
| GB0220936D0 (en) * | 2002-09-05 | 2002-10-23 | Adprotech Ltd | Modified therapeutic agents |
| FR2854897B1 (fr) * | 2003-05-12 | 2007-05-04 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane. |
| US7858108B2 (en) * | 2003-10-21 | 2010-12-28 | Richard Nagler | Elutable surface coating |
| US8454963B2 (en) * | 2003-11-13 | 2013-06-04 | Musc Foundation For Research Development | Tissue targeted complement modulators |
| US8124097B2 (en) * | 2004-01-21 | 2012-02-28 | Case Western Reserve University | Hybrid and chimeric polypeptides that regulate activation of complement |
| WO2005115430A1 (en) | 2004-05-27 | 2005-12-08 | Gropep Limited | Treatment of inflammatory airway disease |
| JP2009508937A (ja) * | 2005-09-22 | 2009-03-05 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | Ｔ細胞免疫を調節するためのジアステレオマーペプチド |
| DE602007010431D1 (de) | 2006-03-09 | 2010-12-23 | Cambridge Entpr Ltd | Neuartige antibiotische zusammensetzungen |
| EP2083841B1 (en) | 2006-10-20 | 2013-11-20 | Celldex Therapeutics, Inc. | SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1) PROTEIN FOR USE IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER DISEASES OF THE EYE |
| US8748371B2 (en) * | 2007-02-28 | 2014-06-10 | Yeda Research And Development Co. Ltd. | Nuclear targeting sequences |
| US8937046B2 (en) | 2008-09-22 | 2015-01-20 | The Regents Of The University Of Colorado, A Body Corporate | Modulating the alternative complement pathway |
| EA021852B1 (ru) * | 2009-02-20 | 2015-09-30 | Ипсен Фарма С.А.С. | Аналоги нейропептида y с заменой на пролин в положении 34 |
| CN102395377B (zh) * | 2009-04-16 | 2016-10-19 | 海德堡吕布莱希特-卡尔斯大学 | 增强肌肉功能的肽 |
| GB0915519D0 (en) | 2009-09-04 | 2009-10-07 | King S College London | Ntithrombotic compounds |
| WO2011050334A1 (en) * | 2009-10-22 | 2011-04-28 | Yong Zhu | Compositions and methods for re-programming cells without genetic modification for treatment of obesity and related diseases |
| CN107661491A (zh) | 2010-09-15 | 2018-02-06 | 赛尔戴克斯治疗公司 | 用可溶性I型补体受体(sCR1)治疗慢性肾病 |
| BR112013010098A2 (pt) | 2010-10-27 | 2017-06-13 | Celldex Therapeutics Inc | método para melhorar a função de transplante usando um receptor do complemento solúvel tipo i (scr1) |
| CA2857168C (en) * | 2011-12-01 | 2020-10-27 | Protevobio, Inc. | Protein inhibitors to complement and vegf pathways and methods of use thereof |
| WO2015017316A2 (en) * | 2013-08-01 | 2015-02-05 | Abbott Nicholas L | Methods and compositions for modifying mucous membranes |
| WO2015040609A1 (en) | 2013-09-17 | 2015-03-26 | Yeda Research And Development Co. Ltd. | Erk-derived peptides and uses thereof |
| GB201402267D0 (en) | 2014-02-10 | 2014-03-26 | Cambridge Entpr Ltd | Antibacterial agents |
| GB2583560A (en) | 2018-12-11 | 2020-11-04 | Admirx Inc | Fusion protein constructs for complement associated disease |
| CN110240656A (zh) * | 2019-04-24 | 2019-09-17 | 中山大学附属第三医院 | 一种融合蛋白及其制备方法与应用 |
| CN110551177A (zh) * | 2019-08-29 | 2019-12-10 | 安徽瑞达健康产业有限公司 | 多肽、多肽衍生物、多肽-抗体复合物及制备、应用 |
| GB201913804D0 (en) | 2019-09-25 | 2019-11-06 | Prostate Cancer Res Centre | Fusion polypeptides |
| WO2024092160A2 (en) * | 2022-10-26 | 2024-05-02 | Flagship Pioneering Innovations Vii, Llc | Bifunctional proteases and uses thereof |
| GB202304385D0 (en) | 2023-03-24 | 2023-05-10 | Prostate Cancer Res | Combinatorial IL-15 therapy |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0109653A3 (en) | 1982-11-17 | 1986-01-29 | Otsuka Pharmaceutical Co., Ltd. | Process for preparing urokinase complex |
| EP0114787B1 (de) * | 1983-01-25 | 1991-09-25 | Ciba-Geigy Ag | Neue Peptidderivate |
| GB8334498D0 (en) | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Compounds |
| GB8400653D0 (en) | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
| NZ215660A (en) | 1985-04-04 | 1990-03-27 | Beecham Group Plc | Tissue plasminogen activator modified in the growth factor domain |
| US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| JP2573007B2 (ja) * | 1987-12-28 | 1997-01-16 | 株式会社成和化成 | 修飾された動物毛粉末 |
| US5256642A (en) | 1988-04-01 | 1993-10-26 | The Johns Hopkins University | Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
| US5582968A (en) * | 1990-02-16 | 1996-12-10 | United Biomedical, Inc. | Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis |
| US6458360B1 (en) | 1990-04-25 | 2002-10-01 | The Johns Hopkins University | Soluble complement regulatory molecules |
| US5326700A (en) | 1990-11-06 | 1994-07-05 | Eli Lilly And Company | DNA sequences encoding t-PA derivatives with cleavable sites |
| WO1993022343A1 (en) * | 1992-05-01 | 1993-11-11 | The Rockfeller University | Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom |
| EP0649468B1 (en) * | 1992-06-24 | 2000-03-15 | AdProTech plc | Soluble cr1 derivatives |
| US5456909A (en) | 1992-08-07 | 1995-10-10 | T Cell Sciences, Inc. | Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo |
| US5856300A (en) * | 1994-05-12 | 1999-01-05 | T Cell Sciences, Inc. | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| DK0730608T3 (da) * | 1993-05-17 | 2002-07-22 | Avant Immunotherapeutics Inc | Præparater omfattende komplementrelaterede proteiner og carbohydrater og fremgangsmåder til fremstilling og anvendelse af præparaterne |
| EP0750458B1 (en) * | 1994-03-03 | 2003-08-27 | Alexion Pharmaceuticals, Inc. | Terminal complement inhibitor fusion genes and proteins |
| GB9614871D0 (en) * | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
| US5776689A (en) | 1996-07-19 | 1998-07-07 | The Regents Of The University Of California | Protein recruitment system |
| JP2002526775A (ja) | 1998-10-01 | 2002-08-20 | テイテイエブスキ，アレクセイ・ウラデイミロビチ | ＧＤＮＦについての新規Ｒｅｔ非依存性シグナリング経路 |
| GB0220936D0 (en) * | 2002-09-05 | 2002-10-23 | Adprotech Ltd | Modified therapeutic agents |
-
1996
- 1996-07-15 GB GBGB9614871.3A patent/GB9614871D0/en active Pending
-
1997
- 1997-07-08 IL IL12803497A patent/IL128034A0/xx active IP Right Grant
- 1997-07-08 DE DE69739186T patent/DE69739186D1/de not_active Expired - Lifetime
- 1997-07-08 EP EP97933665A patent/EP0912730B1/en not_active Expired - Lifetime
- 1997-07-08 ES ES97933665T patent/ES2321245T3/es not_active Expired - Lifetime
- 1997-07-08 NZ NZ333722A patent/NZ333722A/xx unknown
- 1997-07-08 AT AT97933665T patent/ATE419345T1/de not_active IP Right Cessation
- 1997-07-08 WO PCT/EP1997/003715 patent/WO1998002454A2/en not_active Ceased
- 1997-07-08 JP JP50560898A patent/JP4177457B2/ja not_active Expired - Fee Related
- 1997-07-08 AU AU36939/97A patent/AU732725B2/en not_active Ceased
- 1997-07-08 DK DK97933665T patent/DK0912730T3/da active
- 1997-07-08 CA CA002260288A patent/CA2260288A1/en not_active Abandoned
- 1997-07-14 ZA ZA976216A patent/ZA976216B/xx unknown
- 1997-07-14 AR ARP970103142A patent/AR007737A1/es unknown
- 1997-07-15 CO CO97039907A patent/CO4750673A1/es unknown
- 1997-07-18 TW TW086110188A patent/TW538048B/zh not_active IP Right Cessation
-
1999
- 1999-01-13 IL IL128034A patent/IL128034A/en not_active IP Right Cessation
-
2000
- 2000-07-07 US US09/612,314 patent/US6713606B1/en not_active Expired - Fee Related
-
2003
- 2003-12-23 US US10/742,887 patent/US7655617B2/en not_active Expired - Fee Related
-
2004
- 2004-12-30 IL IL16605104A patent/IL166051A0/xx unknown
-
2008
- 2008-08-15 US US12/192,560 patent/US20100286367A1/en not_active Abandoned